NHK reported this morning on the finding that the MHLW is making final arrangements to reach a decision on whether to approve Pfizer’s COVID-19 vaccine at a subcommittee meeting to be convened on Feb. 12. The network said that if the Pfizer vaccine is approved, the MHLW will only administer it to people aged 16 or older for the time being and will not administer it to people who have had serious allergic reactions to immunizations in the past. The network said Pfizer, which signed a deal with the GOJ to provide enough vaccine doses for 72 million people this year, submitted to the GOJ last week the results of its clinical trials conducted in Japan. The network said that once the vaccine is approved by the subcommittee, the MHLW is expected to formally approve it within a few days. The network added that the GOJ is planning to administer the vaccine to medical practitioners starting later this month.